Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696 - Concepedia

Concepedia

Publication | Open Access

Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696

DOI Full Paper Access

138

Citations

36

References

2009

Year

John M. Kirkwood, Stergios Moschos, Mark R. Albertini, John C. Michalak, Cindy Sander, Theresa L. Whiteside, Lisa H. Butterfield, Louis M. Weiner

Clinical Cancer Research

Abstract

Immune response to vaccination correlates with prolonged survival in patients with metastatic melanoma and is not enhanced by immunomodulatory cytokines as tested in this trial.

References

	Year	Citations

Page 1